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C ardiovascular disease remains the leading cause of mortality in the United States; most deaths are attributable to coronary artery disease. Coronary atherosclerosis is an extremely common clinical entity that will be encountered daily by anyone involved with cardiovascular imaging. Although coronary artery disease can result in cardiomyopathy, causing left ventricular failure and arrhythmias, many other disease states also result in myocardial injury that can mimic ischemic symptoms.
A wide variety of cardiomyopathies exist, classified as primary if only the heart muscle is involved or classified as secondary if the heart muscle is involved as part of a more widespread systemic disorder. With the growing use of cardiac MRI to exploit distinguishing tissue characteristics, the underlying cause of cardiomyopathy can be easily identified if one understands the pathologic basis of each disease.
In this article, we review the structural basis of selected cardiomyopathies and show their typical gross and microscopic features. The corresponding characteristic imaging findings of each disease are then presented. Differentiating the cause of the cardiomyopathies on the basis of imaging is an important service that the radiologist can provide the patient, potentially averting the need for OBJECTIVE. This article will present correlation of the key radiologic findings with gross and microscopic pathology for the characterization of diffuse myocardial diseases using advanced imaging techniques. Our goal is to provide a focused and in-depth review of the pathophysiology underlying each entity and to emphasize the structural basis for the corresponding imaging characteristics. This article is limited to those disorders characterized by ventricular wall thickening without chamber dilatation, including hypertrophic cardiomyopathy, hypertensive cardiomyopathy, and cardiac amyloidosis.
CONCLUSION. For the characterization of diffuse myocardial diseases using advanced imaging techniques, it is essential to understand the underlying pathologic changes in the heart. With these techniques, such as cardiac MRI, the various cardiomyopathies can be differentiated accurately, which may potentially obviate invasive testing and endomyocardial biopsy.
Diffuse Diseases of the Myocardium
When present, symptoms often include syncope, chest pain, or dyspnea on exertion. Treatment decisions may be adjusted on the basis of three clinical paths: presence of left ventricular (LV) outflow obstruction, high risk of sudden death, and progressive symptoms [1] . Accepted risk factors for sudden cardiac death include family history of sudden death, unexplained syncope, sustained or unsustained ventricular tachycardia, abnormal blood pressure response to exercise, and extreme LV hypertrophy (> 30 mm) [2] . Many genetic mutations have been linked to hypertrophic cardiomyopathy, with most involving sarcomeric proteins [3] .
Pathology
On gross examination of the heart, typical findings include thickened ventricular walls and increased cardiac mass (with heart weights 50-150% above the expected mean value, based on sex and body size) (Fig. 1) . Small patchy areas of fibrosis may also be visible grossly. Mitral papillary muscles tend to be particularly hypertrophied and prominent. Although severe LV hypertrophy is considered a risk factor for sudden cardiac death, a relatively normal LV wall thickness does not protect against sudden cardiac death.
In at least 90% of patients with HCM, the ventricular septum is disproportionately hypertrophied, such that the ratio of septal to LV free wall thicknesses is > 1.3 (Fig. 1) . The asymmetrically hypertrophied region may extend onto the anterior or inferior free walls or, rarely, may be limited to the free wall without septal involvement. Excessive hypertrophy of the ventricular septum may be limited to the subaortic, midventricular, or apical regions or may involve the entire septum from base to apex. In < 10% of patients with HCM, the LV hypertrophy is symmetric, without disproportionate thickening.
In cases with septal wall predominance, the LV luminal space may be decreased, with or without LV outflow tract obstruction. Displacement of the mitral papillary muscles and the anterior mitral leaflet or inherently abnormal papillary muscles and valve leaflets can lead to mechanical damage, with thickening and fibrosis of the leaflets and tendinous cords [3] . Studies have shown that patients with HCM have a greater frequency of intrinsic papillary muscle and mitral valve leaflet abnormalities than those without HCM [3, 4] .
Along the subaortic septum, a patchy area of fibrosis in the mirror-image shape of the anterior mitral leaflet is commonly observed in patients with LV outflow tract obstruction. This is thought to be the result of repeated contact by the anterior mitral valve leaflet against the ventricular septum with each cardiac cycle [5] .
Key findings on microscopic examination include appreciable myocyte hypertrophy (with 
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increased cell diameters and large hyperchromatic nuclei), myocyte disarray, focal interstitial fibrosis, and patchy endocardial fibrosis [3, 5, 6] . Myocyte disarray is characterized by myocytes oriented obliquely and perpendicularly to each other in whorls or in a herringbone pattern (Fig. 2 ). Of note, myocyte disorganization is not specific for HCM but is usually more prominent in HCM than in other types of heart disease [5] [6] [7] . Other less-specific findings include intramural arteriolar dysplasia and dilated venous channels.
Radiology

Cardiac MRI represents a noninvasive means to evaluate chamber morphology and function in HCM while also showing papillary muscle or mitral valve abnormalities, perfusion abnormalities, and fibrosis with late gado-A B When it is present, systolic anterior motion of the anterior mitral valve leaflet will generally also be seen (Fig. 3) . Anterior motion of the mitral valve during systole, which is often seen best on cine steady state free precession (SSFP) images in the three-chamber long-axis view, can further exacerbate LV outflow obstruction and lead to mitral regurgitation. Repetitive impaction of the leaflet on the septal surface commonly leads to patchy endocardial fibrosis in the mirror-image shape of the anterior mitral leaflet.
Subtypes of HCM include the septal-predominant type (most common), asymmetric HCM with reversed septal contour ( 
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Giesbrandt et al. midventricular obstruction, apical HCM, and symmetric (or concentric) HCM. As indicated by the variation in appearance, the cardiac segments involved by wall thickening can range from few to many, and the segmental involvement is not necessarily contiguous [4] . Because of the segmental thickening of the wall, measurements at multiple levels of the LV (apical, mid, and basal) are often performed. The hearts of many patients show < 50% of the total segments involved [8] .
Overall increased LV mass index has been shown to correlate with worse clinical outcomes, but this is not a requirement for diagnosis, with one group of investigators reporting 21% of HCM patients with a normal range LV mass index [9] . Accepted standards for hypertrophy include an end-diastolic LV wall thickness of ≥ 17 mm and a septal-tofree-wall thickness ratio of > 1.3 [3] .
Foci of late gadolinium enhancement usually occur in areas of hypertrophy, and late gadolinium enhancement has also been correlated with increased interstitial collagen. Fibrosis, with corresponding late gadolinium enhancement, may be seen in HCM. Although late gadolinium enhancement is not specific for HCM, a patchy nonvascular distribution in the midventricular wall and along the right ventricular insertion points on the septum, which can also be seen in pulmonary hypertension, are suggestive of HCM (Fig. 5) . 
Diffuse Diseases of the Myocardium
Postulated causes for fibrotic changes and late gadolinium enhancement include, but are not limited to, increased collagen deposition, inherent microvascular dysplasia with subsequent ischemia, and ischemic changes secondary to a supply-and-demand mismatch related to the prominent myocyte hypertrophy [1, 3, 4, 10] . Late gadolinium enhancement has correlated clinical prognostic significance, with worse clinical outcomes when present [2] [3] [4] .
Hypertensive Cardiomyopathy
Chronic systemic arterial hypertension is widely prevalent among the adult population in the United States. Hypertensive cardiomyopathy represents left ventricular hypertrophy (LVH) that has resulted from a heart pumping against chronically increased back pressure, usually from systemic hypertension or, less commonly, aortic valvular stenosis.
In the case of the latter, associated findings, such as a bicuspid aortic valve or poststenotic dilatation of the ascending aorta, may be present. Hypertensive heart disease is linked to an increase in adverse cardiac events, such as arrhythmia, atrial fibrillation, heart failure, and myocardial infarct [11] . Additionally, LVH itself is associated with increased cardiac mortality regardless of cause [12] . The heart failure associated with hypertensive cardiomyopathy often involves diastolic dysfunction. However, as subendocardial interstitial fibrosis increases, myocardial contractility can be compromised and eventually lead to systolic dysfunction as well [13] .
Pathology
Hypertension is the most common cause of LVH. The hypertrophy is characteristically symmetric, without disproportionate septal thickening. Patchy subendocardial fibrosis may be evident grossly (Fig. 6) . Microscopically, cardiac myocytes show the typical features of pressure hypertrophy, including increased cell diameters, prominent hyperchromatic nuclei, and focal nuclear replication.
Small areas of subendocardial fibrosis are commonly observed and are associated with proliferation of fibroblasts. The fibrosis may be interstitial or perivascular. This is thought to be due to increased collagen deposition and decreased degradation [13] . Fibrosis may involve not only the left ventricle but also the right ventricle and one or both atria. In general, the severity of hypertrophy and fibrosis correspond with the severity and duration of hypertension.
Hypertrophy and hyperplasia of smooth muscle cells in the media of myocardial arterioles may also be detected [11, 13] . Other vascular lesions include a decrease in the A B A B Fig. 8 
Fig. 9-Cardiac amyloidosis.
A and B, Short-axis delayed contrast-enhanced MR images in healthy patient (A) and patient with amyloidosis (B). Deposition of amyloid leads to poor nulling of myocardium relative to blood pool. Normal cardiac muscle can be nulled to black whereas blood pool appears white. In contrast, in patients with amyloidosis, myocardium remains diffusely bright and of similar signal intensity to blood pool.
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number (or density) of capillaries, which also predisposes to ischemia [13] .
Radiology
Cardiac MRI provides a method to reproducibly measure LV mass and LVH in addition to evaluating for fibrosis. Given the prognostic implications of LVH and fibrosis, this ability is of utmost importance. Moreover, because treatment with angiotensin-converting enzyme inhibitors has been shown to decrease the myocardial collagen content and possibly cause regression of hypertrophy, reproducible serial measurements may be needed [11, 13] .
LVH and increased LV wall thickness are morphologically evident on cardiac MRI (Fig.  6 ). These findings can be difficult to distinguish from hypertrophic cardiomyopathy, particularly in older patients with an age-related subaortic septal bulge. In this regard, Sipola et al. [14] showed that LVH in hypertensive cardiomyopathy is more symmetric, with maximum wall thickness usually involving the septum. In contrast, HCM is more asymmetric, with greater involvement of the anterior free wall and septum. HCM patients also occasionally show regional septal bulge and right ventricular hypertrabeculation, whereas this is not seen with hypertensive cardiomyopathy.
Sipola and colleagues [14] also found that a maximum wall thickness of ≥ 17 mm was the most accurate feature in diagnosing HCM versus mild or moderate hypertensive LVH. It is important to note, however, that patients with severe hypertension can have wall thicknesses measuring > 20 mm. Fibrosis, as shown by late gadolinium enhancement, is not as commonly encountered in hypertensive cardiomyopathy as with HCM [14] . When present, there is usually no specific pattern of late gadolinium enhancement except that it is usually not subendocardial [11, 12] . If seen, this is a useful finding because late gadolinium enhancement is associated with worse diastolic dysfunction [11, 15] .
Cardiac Amyloidosis
Amyloidosis is an infiltrative process characterized by the extracellular deposition of glycoproteins into various tissues and organs. Several subtypes of amyloidosis exist. However, cardiac involvement is most commonly either of the primary AL type, associated with abnormal λ or κ light chains produced by plasma cells, or of the ATTR type, in which abnormal transthyretin is produced by the liver and may represent either familial amyloidosis or senile systemic amyloidosis [16] .
Approximately half of the patients with primary amyloidosis exhibit features of cardiac involvement [17] . The myocardial interstitial deposition of amyloid glycoproteins leads to restrictive hemodynamics, which can clinically present as congestive heart failure, arrhythmias, or sudden cardiac death. Congestive heart failure is associated with an especially poor prognosis, with a median survival of < 6 months after the onset of symptoms [18] .
Pathology
The deposition of amyloid fibrils occurs as a result of protein misfolding, which leads to the formation of β-pleated sheets [19] . When amyloid fibers are stained with Congo red and examined microscopically under crosspolarization, they characteristically exhibit apple-green birefringence. These bloodborne misfolded proteins may accumulate in various organs and tissues. Aggregation of amyloid protein and enlargement of the organs can lead to organ dysfunction.
In the heart, the amorphous interstitial amyloid fibrils are generally deposited along the sarcolemmal membrane of myocytes. Because amyloid has a firm consistency, its deposition in the heart eventually leads primarily to diastolic dysfunction. Over time, entrapped myocytes, in which uptake of oxygen and nutrients and release of carbon dioxide and other waste products has been hampered by coating of amyloid, can become atrophic. Moreover, amyloid can deposit within small intramural coronary arteries and may cause sufficient luminal narrowing to cause microfocal areas of ischemic injury.
The classic findings of amyloidosis with cardiac dysfunction are substantial thickening of the ventricular walls without chamber dilatation and thickening of the atrial endocardium and atrial septum. Both atria tend to dilate in response to elevated ventricular enddiastolic pressures. In later stages of the disease, amyloid infiltration of the valve leaflets may occur and lead to valve dysfunction [20] . A mild degree of ventricular dilatation can develop in the setting of end-stage disease.
Radiology
The gross findings of biatrial enlargement with ventricular, atrial, septal, and valvular thickening are easily identified on cardiac MRI (Fig. 7) . Pleural and pericardial effusions are commonly seen as well [21] . Amyloid deposition in the myocardium changes the intrinsic characteristics of the tissue, which, in turn, results in changes in signal intensity on T1-weighted imaging [22] . Amyloid deposition also results in diffuse enhancement of the myocardium with late gadolinium enhancement, as seen in Figure 8 . This late gadolinium enhancement may be more prominent in the subendocardial region but nonvascular in distribution, which differentiates this finding from those seen in coronary ischemic disease. Nulling of the myocardium infiltrated with amyloid protein may occur at a shorter inversion time than the blood pool, which is the opposite of normal myocardium [23] (Fig. 9) . This may cause difficulty in determining the optimal inversion time, which in and of itself should raise concern for amyloidosis.
Summary
A thorough understanding of the pathophysiology underlying the nondilated cardiomyopathies allows easier identification of the corresponding imaging characteristics.
